What Place Is There for Long-Acting Antibiotics in the Management of Gram-Positive Infections? A Qualitative Cross-Sectional Study.

Aurélien Dinh Guillaume BéraudJohan CourjonYann Le GoffNicolas Kader EttaharMatthieu GrégoireEric Senneville

Published in: Antibiotics (Basel, Switzerland) (2024)

Long half-life lipoglycopeptides contribute to changing the paradigm in the management of acute bacterial infections, as infectiologists now consider a range of indications and patient profiles for one single drug. Oritavancin strengthens the therapeutic arsenal in numerous infections from BJIs to urinary tract infections and could help to manage specific clinical situations, on top of providing potential benefits for the hospital's budget.

Keyphrases

urinary tract infection
healthcare
drug induced
adverse drug
intensive care unit
climate change
acute respiratory distress syndrome
mechanical ventilation